$GAQ
Generation Asia I Acquisition Ltd

2024 Q2 Form 10-Q Financial Statement

#000095017024096318 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $247.6K
YoY Change -31.85%
Operating Profit -$247.6K
YoY Change -31.85%
Interest Expense $543.1K
YoY Change -79.74%
% of Operating Profit
Other Income/Expense, Net $1.277M
YoY Change -72.94%
Pretax Income $1.029M
YoY Change -76.37%
Income Tax
% Of Pretax Income
Net Earnings $1.029M
YoY Change -76.37%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.11
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $129.8K
YoY Change 67.35%
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets $49.89K
YoY Change -83.69%
Inventory
Prepaid Expenses $49.89K
Receivables $2.200K
Other Receivables $2.199K
Total Short-Term Assets $181.9K
YoY Change -52.55%
LONG-TERM ASSETS
Property, Plant & Equipment $26.58M
YoY Change -88.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $26.58M
YoY Change -88.46%
TOTAL ASSETS
Total Short-Term Assets $181.9K
Total Long-Term Assets $26.58M
Total Assets $26.76M
YoY Change -88.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00
YoY Change -100.0%
Accrued Expenses $553.0K
YoY Change -11.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.053M
YoY Change 281.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $733.8K
YoY Change 0.5%
Total Long-Term Liabilities $733.8K
YoY Change 0.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.053M
Total Long-Term Liabilities $733.8K
Total Liabilities $6.787M
YoY Change 49.81%
SHAREHOLDERS EQUITY
Retained Earnings -$6.605M
YoY Change 59.25%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.605M
YoY Change
Total Liabilities & Shareholders Equity $26.76M
YoY Change -88.4%

Cashflow Statement

Concept 2024 Q2
OPERATING ACTIVITIES
Net Income $1.029M
YoY Change -76.37%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$347.2K
YoY Change 492.22%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $59.29M
YoY Change
Cash From Investing Activities $59.29M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -58.95M
YoY Change
NET CHANGE
Cash From Operating Activities -347.2K
Cash From Investing Activities 59.29M
Cash From Financing Activities -58.95M
Net Change In Cash -2.220K
YoY Change -96.21%
FREE CASH FLOW
Cash From Operating Activities -$347.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001852061
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2024Q2 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41239
dei Entity Registrant Name
EntityRegistrantName
GENERATION ASIA I ACQUISITION LIMITED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1588665
dei Entity Address Address Line1
EntityAddressAddressLine1
Boundary Hall
dei Entity Address Address Line2
EntityAddressAddressLine2
Cricket Square
dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
dei Entity Address Country
EntityAddressCountry
KY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1102
dei City Area Code
CityAreaCode
345
dei Local Phone Number
LocalPhoneNumber
814-5580
dei Security12b Title
Security12bTitle
Class A ordinary shares, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
GAQ
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 us-gaap Cash
Cash
129829
CY2023Q4 us-gaap Cash
Cash
320144
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
49886
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
26481
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2199
CY2024Q2 us-gaap Assets Current
AssetsCurrent
181914
CY2023Q4 us-gaap Assets Current
AssetsCurrent
346625
CY2024Q2 gaq Investments Held In Trust Account Noncurrent
InvestmentsHeldInTrustAccountNoncurrent
26577291
CY2023Q4 gaq Investments Held In Trust Account Noncurrent
InvestmentsHeldInTrustAccountNoncurrent
83854821
CY2024Q2 us-gaap Assets
Assets
26759205
CY2023Q4 us-gaap Assets
Assets
84201446
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
552969
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
546000
CY2024Q2 gaq Promissory Note Related Party
PromissoryNoteRelatedParty
2500000
CY2023Q4 gaq Promissory Note Related Party
PromissoryNoteRelatedParty
1500000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
27801
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3052969
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2073801
CY2024Q2 gaq Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
733760
CY2023Q4 gaq Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
550320
CY2024Q2 gaq Deferred Underwriting Commissions
DeferredUnderwritingCommissions
3000000
CY2023Q4 gaq Deferred Underwriting Commissions
DeferredUnderwritingCommissions
3000000
CY2024Q2 us-gaap Liabilities
Liabilities
6786729
CY2023Q4 us-gaap Liabilities
Liabilities
5624121
CY2024Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
2357355
CY2024Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
11.27
CY2023Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
7699729
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.89
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
2357355
CY2023Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
7699729
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6605363
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5278244
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-6604815
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5277496
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26759205
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84201446
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
247586
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
363278
us-gaap Operating Expenses
OperatingExpenses
663879
us-gaap Operating Expenses
OperatingExpenses
625604
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-247586
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-363278
us-gaap Operating Income Loss
OperatingIncomeLoss
-663879
us-gaap Operating Income Loss
OperatingIncomeLoss
-625604
CY2024Q2 us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
543052
CY2023Q2 us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
2680608
us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
1638421
us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
5121773
CY2023Q2 gaq Gain Loss From Debt Forgiven
GainLossFromDebtForgiven
126472
gaq Gain Loss From Debt Forgiven
GainLossFromDebtForgiven
126472
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-733760
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1911445
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
183440
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-77045
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1276812
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4718525
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1454981
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5325290
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1029226
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
4355247
us-gaap Net Income Loss
NetIncomeLoss
791102
us-gaap Net Income Loss
NetIncomeLoss
4699686
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5277496
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-238124
CY2024Q1 gaq Adjustments To Additional Paid In Capital Re Measurement Of Carrying Value To Redemption Value
AdjustmentsToAdditionalPaidInCapitalReMeasurementOfCarryingValueToRedemptionValue
-1470369
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6985989
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1029226
CY2024Q2 gaq Adjustments To Additional Paid In Capital Re Measurement Of Carrying Value To Redemption Value
AdjustmentsToAdditionalPaidInCapitalReMeasurementOfCarryingValueToRedemptionValue
-648052
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-6604815
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8273909
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
344439
CY2023Q1 gaq Adjustments To Additional Paid In Capital Re Measurement Of Carrying Value To Redemption Value
AdjustmentsToAdditionalPaidInCapitalReMeasurementOfCarryingValueToRedemptionValue
-2441165
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-10370635
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
4355247
CY2023Q2 gaq Adjustments To Additional Paid In Capital Re Measurement Of Carrying Value To Redemption Value
AdjustmentsToAdditionalPaidInCapitalReMeasurementOfCarryingValueToRedemptionValue
-2680608
CY2023Q2 gaq Adjustments To Additional Paid In Capital Forgiven Of Deferred Underwriter Commissions
AdjustmentsToAdditionalPaidInCapitalForgivenOfDeferredUnderwriterCommissions
4549028
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4146968
us-gaap Profit Loss
ProfitLoss
791102
us-gaap Profit Loss
ProfitLoss
4699686
gaq Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
1638421
gaq Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
5121773
gaq Gain Loss From Debt Forgiven
GainLossFromDebtForgiven
126472
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
183440
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-77045
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
23405
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-191052
gaq Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
6969
gaq Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
164055
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-30000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
60000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-710315
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-210497
gaq Payments To Acquire Investments Held In Trust Account
PaymentsToAcquireInvestmentsHeldInTrustAccount
453869227
gaq Proceeds From Disposal Of Investments Held In Trust Account
ProceedsFromDisposalOfInvestmentsHeldInTrustAccount
59395951
gaq Proceeds From Disposal Of Investments Held In Trust Account
ProceedsFromDisposalOfInvestmentsHeldInTrustAccount
453869227
gaq Payment To Cash Deposited In Trust Account
PaymentToCashDepositedInTrustAccount
480000
gaq Payment To Cash Deposited In Trust Account
PaymentToCashDepositedInTrustAccount
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
58915951
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
59395951
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-58395951
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-190315
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-210497
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
320144
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
288081
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129829
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77584
gaq Re Measurement Of Carrying Value Of Shares Subject To Possible Redemption To Redemption Value
ReMeasurementOfCarryingValueOfSharesSubjectToPossibleRedemptionToRedemptionValue
2118421
gaq Re Measurement Of Carrying Value Of Shares Subject To Possible Redemption To Redemption Value
ReMeasurementOfCarryingValueOfSharesSubjectToPossibleRedemptionToRedemptionValue
5121773
gaq Waiver Of Deferred Underwriting Commissions
WaiverOfDeferredUnderwritingCommissions
4549028
CY2023Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
gaq Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
1
gaq Amount Of Interest To Pay Dissolution Expenses
AmountOfInterestToPayDissolutionExpenses
100000
CY2024Q2 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
gaq Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
1
gaq Amount Of Interest To Pay Dissolution Expenses
AmountOfInterestToPayDissolutionExpenses
100000
CY2024Q2 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
gaq Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
1
CY2024Q2 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
CY2024Q2 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
CY2024Q2 gaq Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
10.1
CY2023Q3 gaq Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
723690
CY2023Q3 us-gaap Share Price
SharePrice
0.03
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.52
CY2023Q3 gaq Temporary Equity Redeemed During Period Value
TemporaryEquityRedeemedDuringPeriodValue
149750000
CY2023Q3 gaq Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
125000
CY2023Q3 gaq Business Combination Aggregate Deposit To Trust Account By Related Parties
BusinessCombinationAggregateDepositToTrustAccountByRelatedParties
1125000
CY2024Q2 gaq Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
35000
CY2024Q2 us-gaap Share Price
SharePrice
0.03
CY2024Q2 gaq Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
35000
CY2024Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
11.12
CY2024Q2 gaq Common Stock Redemption Percentage
CommonStockRedemptionPercentage
0.69
CY2024Q2 gaq Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
35000
CY2024Q2 gaq Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
35000
CY2024Q2 gaq Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
35000
CY2024Q2 us-gaap Cash
Cash
129829
CY2024Q2 gaq Working Capital Deficit
WorkingCapitalDeficit
2871055
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liability and over-allotment liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company has not experienced losses on this account.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2024Q2 us-gaap Cash
Cash
129829
CY2023Q4 us-gaap Cash
Cash
320144
CY2023Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
CY2024Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
0
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
27801
us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
10000
CY2022Q1 gaq Gross Proceeds From Over Allotment Option
GrossProceedsFromOverAllotmentOption
19300000
CY2023Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
CY2024Q2 gaq Remaining Deferred Underwriting Commissions
RemainingDeferredUnderwritingCommissions
3000000
CY2024Q2 gaq Payable To Underwriter In Cash
PayableToUnderwriterInCash
1000000
CY2024Q2 gaq Payable To Underwriter In Share
PayableToUnderwriterInShare
200000
CY2024Q2 gaq Nominal Value Price Per Share
NominalValuePricePerShare
10
CY2024Q2 gaq Aggregate Nominal Value
AggregateNominalValue
2000000
CY2023Q2 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
4675500
CY2023Q4 gaq Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
126472
CY2023Q2 gaq Remaining Deferred Underwriting Commissions
RemainingDeferredUnderwritingCommissions
4549028
CY2024Q2 gaq Deferred Underwriting Commissions
DeferredUnderwritingCommissions
3000000
CY2023Q4 gaq Deferred Underwriting Commissions
DeferredUnderwritingCommissions
3000000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
26577291
CY2024Q2 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
733760
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
83854821
CY2023Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
550320
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-24-096318-index-headers.html Edgar Link pending
0000950170-24-096318-index.html Edgar Link pending
0000950170-24-096318.txt Edgar Link pending
0000950170-24-096318-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gaq-20240630.htm Edgar Link pending
gaq-20240630.xsd Edgar Link pending
gaq-ex31_1.htm Edgar Link pending
gaq-ex31_2.htm Edgar Link pending
gaq-ex32_1.htm Edgar Link pending
gaq-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gaq-20240630_htm.xml Edgar Link completed